← Back to headlines
Insmed Reaffirms BRINSUPRI Revenue Target and ARIKAYCE Expansion
Insmed has reiterated its target of at least $1 billion in BRINSUPRI revenue by 2026 and is aiming for ARIKAYCE label expansion in the first half of 2027.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
